Aqr Capital Management LLC Biogen Inc. Transaction History

Aqr Capital Management LLC

$64.6 Billion
Q2 2024

A detailed history of Aqr Capital Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 23,557 shares of BIIB stock, worth $4.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,557

Previous 6,362 270.28%

Holding current value

$4.09 Million

Previous $1.37 Million 298.25%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $3.28 Million - $4.07 Million	17,195 Added 270.28%	23,557 $5.46 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $6.53 Million - $8.24 Million	-30,778 Reduced 82.87%	6,362 $1.37 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $60 Million - $72.2 Million	-269,539 Reduced 87.89%	37,140 $9.61 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $7.53 Million - $8.49 Million	-29,709 Reduced 8.83%	306,679 $78.8 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $23.7 Million - $27.4 Million	-86,098 Reduced 20.38%	336,388 $95.8 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $57.6 Million - $65.7 Million	224,668 Added 113.57%	422,486 $117 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $14.3 Million - $17.4 Million	-56,640 Reduced 22.26%	197,818 $54.8 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $50.4 Million - $69.5 Million	-258,748 Reduced 50.42%	254,458 $65.8 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $21.9 Million - $26.1 Million	116,900 Added 29.5%	513,206 $103 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $13.2 Million - $16.6 Million	68,085 Added 20.74%	396,306 $83.5 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5.07 Million - $6.51 Million	-22,639 Reduced 6.45%	328,221 $78.7 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $46.3 Million - $60.4 Million	-163,602 Reduced 31.8%	350,860 $99.3 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $132 Million - $212 Million	-510,943 Reduced 49.83%	514,462 $178 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1.94 Million - $2.27 Million	7,983 Added 0.78%	1,025,405 $284 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $283 Million - $427 Million	-1,199,563 Reduced 54.11%	1,017,422 $245 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $5.08 Million - $5.87 Million	-19,186 Reduced 0.86%	2,216,985 $628 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $30 Million - $39.8 Million	116,044 Added 5.47%	2,236,171 $583 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $139 Million - $176 Million	-516,832 Reduced 19.6%	2,120,127 $661 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $194 Million - $267 Million	-879,652 Reduced 25.01%	2,636,959 $781 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $60.3 Million - $67.6 Million	-277,141 Reduced 7.31%	3,516,611 $815 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $93.4 Million - $103 Million	-426,104 Reduced 10.1%	3,793,752 $887 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $231 Million - $361 Million	1,063,775 Added 33.71%	4,219,856 $992 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $36.8 Million - $46.6 Million	132,044 Added 4.37%	3,156,081 $950 Million
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $53.9 Million - $70.4 Million	183,542 Added 6.46%	3,024,037 $1.07 Billion
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $102 Million - $122 Million	396,445 Added 16.22%	2,840,495 $824 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $124 Million - $176 Million	477,916 Added 24.31%	2,444,050 $669 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $29.7 Million - $33.2 Million	96,473 Added 5.16%	1,966,134 $626 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $526 Million - $616 Million	1,869,661	1,869,661 $585 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Biogen Inc. Transaction History